Edwards Lifesciences EW Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.07B-74.4% | $4.17B+198% | $1.4B-8.0% | $1.52B+1.3% | ||
| $156.6M+0.9% | $155.2M+7.1% | $144.9M+3.8% | $139.6M+3.6% | ||
| $158.1M-2.6% | $162.3M+16.4% | $139.4M+9.9% | $126.8M+16.0% | ||
| -$52.5M-120% | $256.1M-11.4% | $289M+35.4% | $213.4M— | ||
| $395.1M+327% | $92.6M-36.6% | $146M— | —— | ||
| —— | $22.4M— | —— | $52M— | ||
| —— | -$186.7M-3,119% | -$5.8M— | —— | ||
| $1.6B— | —— | $895.8M-26.5% | $1.22B-29.7% | ||
| $260.2M+3.1% | $252.4M-0.2% | $253M+3.4% | $244.6M-24.9% | ||
| $64.8M— | —— | $15.8M— | —— | ||
| $3.09B+244% | $899.9M+9,789% | $9.1M-97.1% | $315.8M-80.6% | ||
| $62.1M+8.0% | $57.5M-41.3% | $97.9M-76.7% | $419.5M+204% | ||
| -$712.9M— | —— | $173.8M— | —— | ||
| $893.4M-22.9% | $1.16B+31.8% | $879.6M-49.1% | $1.73B+237% | ||
| -$1.01B+0.2% | -$1.01B-32.6% | -$763.1M+51.8% | -$1.58B— | ||
| -$48.3M-225% | $38.6M— | —— | —— | ||
| —— | —— | —— | -$94.8M+71.5% | ||
| —— | —— | —— | $55.1M+1,278% | ||
| —— | —— | —— | $0— | ||
| —— | —— | —— | —— | ||
| —— | -$121.2M-185% | $142.5M+69.4% | $84.1M— | ||
| $117.6M-63.6% | $323.4M+18.9% | $272.1M+6.9% | $254.5M+515% | ||
| -$76.5M-108% | -$36.8M-11.5% | -$33M+26.7% | -$45M-54.1% | ||
| $23.7M— | —— | $81.8M— | —— | ||
| $25.9M-6.8% | $27.8M-1.4% | $28.2M+3.7% | $27.2M-4.6% | ||
| —— | -$13.2M-50.0% | -$8.8M— | —— | ||
| $25.1M-45.7% | $46.2M— | —— | $109.6M— | ||
| $7.9M— | —— | -$3.3M-111% | $28.8M-35.1% | ||
| $43.3M-5.7% | $45.9M-30.9% | $66.4M-81.2% | $353.5M+41.4% | ||
| $140.9M+124% | $63M+0.8% | $62.5M+19.5% | $52.3M— | ||
| $2.82B+252% | $800.1M+29.5% | $617.9M-34.2% | $939.6M+140% | ||
| -$3.8M-18.8% | -$3.2M— | —— | -$3.9M— | ||
| $174.1M-3.0% | $179.5M+5.7% | $169.9M+16.1% | $146.4M-7.7% | ||
| —— | -$3.93B— | $0— | —— | ||
| —— | —— | —— | —— | ||
| —— | $1.06B— | —— | $0— | ||
| $1.34B— | —— | $657.1M-32.5% | $973.6M-30.8% | ||
| $1.34B— | —— | $657.1M-32.5% | $973.6M-30.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Edwards Lifesciences generate?
- Edwards Lifesciences (EW) generated $1.4B in operating cash flow over the trailing twelve months.
- What is Edwards Lifesciences's free cash flow?
- After $269.1M of capital expenditures, Edwards Lifesciences's free cash flow was $1.1B over the trailing twelve months, up 57.5% year over year.
- Where does Edwards Lifesciences's cash flow data come from?
- Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
